New WHO report shows that transparency and cooperation help to reduce high prices for new medicines

The study illustrates the challenges for national health systems, with specific examples, and shows that few countries in the WHO European Region have mechanisms in place to evaluate the cost effectiveness of new drugs; this hampers the value-assessment and decision-making processes.
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: Tags: *** Editor's Pick Practical therapeutics Cost effectiveness Industry News Affordability Latest News national health systems new medicines WHO regional office Source Type: news